Your browser doesn't support javascript.
loading
Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study.
Su, Junnan; Xu, Meihong; Dong, Zhigao; Wang, Qingqing; Ma, Lili; Xiao, Pingping; Chen, Xuyan.
Affiliation
  • Su J; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
  • Xu M; Department of Physical Examination, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
  • Dong Z; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
  • Wang Q; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
  • Ma L; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
  • Xiao P; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
  • Chen X; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Hematology ; 28(1): 2196864, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37014744

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azathioprine / Prednisone / Purpura, Thrombocytopenic, Idiopathic Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hematology Journal subject: HEMATOLOGIA Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azathioprine / Prednisone / Purpura, Thrombocytopenic, Idiopathic Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hematology Journal subject: HEMATOLOGIA Year: 2023 Document type: Article Country of publication: